Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsF2G

F2G

Biotechnology

Novo Holdings Portfolio Company F2G Enters Strategic Collaboration With Shionogi to Commercialise Its New Antifungal Agent Olorofim in Europe and Asia

PR Newswire -
Novo Holdings A/S, a leading international life sciences investor, announces that its portfolio company F2G Ltd. (F2G) has entered into a strategic collaboration with...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us